Switzerland Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
October 22, 2014
102 Pages - SKU: BMI5361577
Countries covered: Switzerland

Switzerland Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of the pensionable population is high andgrowing, and this will translate into greater demand for drugs. Furthermore, the country's highly developedinfrastructure means that access to healthcare is easy, further supporting the consumption of medicines.

Headline Expenditure Projections

Pharmaceuticals: CHF7.06bn (USD7.68bn) in 2013 to CHF7.02bn (USD7.34bn) in 2014; -0.63% inlocal currency terms and -4.4% in US dollar terms.

Healthcare: CHF68.18bn (USD74.11bn) in 2013 to CHF69.45bn (USD72.61bn) in 2014; +1.9% growthin local currency terms and -2.0% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
Portugal Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Portugal Pharmaceuticals and Healthcare Report Q4 2014BMI View: Despite Portugal's stronger-than-expected economic expansion in previous quarters,government austerity measures will continue to weigh on drug spending ...
See all reports like this >>

More Switzerland Prescription Drugs reports

The Pharmaceutical Market: Switzerland by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Switzerland (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Pharmaceuticals - Switzerland by Global Research & Data Services
This market analysis gives an overview of the actual situation, trends and future outlook of the pharmaceutical market in Switzerland. The market analysis provides essential ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!